Bio (midsize) and reasoning

I am the inventor and developer of tissue-biosensing of folliculogenesis in vivo, and a longtime biomedical entrepreneur. (You can see my face at I am committed to commercialization of the Folliculogenesis In Vivo™ ovulographic™ (cervical tissue sensing) technology.

What for: Non-interventional (pseudo-)hormone-free reproductive management (i.e. sex life management) for women’s self-help & diagnostic menstrual cycle vital sign profiles for doctors & insurance payers.

Tweetroducing bioZhena in 8 slides

Tweetroducing bioZhena in 8 slides

I am thinking: Evidence-based medicine, Personalized medicine, eHealth, Self-care.

Taking this well beyond and beyond .

Monitoring the menstrual cycle ovulographic™ signatures will be essential for patient profiling with which to manage women’s frequent menstrual and fertility, reproductive and general health problems. (Illustrated in a single animated slide.) The menstrual cyclic profiles, recorded at home, are descriptive of reproductive cycling and relate to a woman’s well-being – somewhat similar to (though not as “granular” as) how EKG recordings pertain to the health of the heart.

There was a period of privately funded R&D before I founded bioZhena Corporation, and not without expenditures including blood, sweat and tears… which was not much different from the experience with my predecessor company, CTI (Conception Technology Inc).

I had started CTI with my own funds (voluntary severance from Wellcome Foundation Ltd. plus 100% profit from house sale near London when they completed the orbital motorway and home appraisals within reasonably easy reach shot up). We started the biomedical technology project some years prior, out of the need to overcome the surprising difficulty to conceive a pregnancy.

A son and a daughter proved that “sterile marriage” was a wrong diagnosis and that “the right time” was a key concept in female reproductive management. Really *key* in baby-making practice, and – if you think and learn about it – due to the chronobiological aspects of women’s (not only reproductive) health! You might see about this under “Biological rhythms and chronobiology” in the Alphabet of bioZhena , 2007 edition. (Re: my “eukairosic” labeling of an aspect – initially the key aspect – of the bioZhena medtech.)

I acquired experience with Private Placement Memorandum Offering (PPM, reg D) and private investing by non-accredited investors in Colorado (USA). Prior to this, I was for a decade Senior Research Scientist at the big-pharma firm Wellcome Foundation Ltd. (Glaxo-Wellcome, now GSK) in pharmaceutical bio-electrochemistry exploratory research; and before that a Research Fellow investigating electro-acupuncture at the City University of London, UK.

After the 5 mostly bootstrapping years with CTI, I realized that I was the inventor of tissue-biosensing of folliculogenesis in vivo – meaning the significantly broader applicability of the technology. Earlier, we simply had a superior technique of predicting and also uniquely detecting ovulation, which was not understood by professional investors in those years before fertility problems became a medialized hot topic.

My many private placement subscribers – mostly women – could see the superiority in the performance data. But trying to emulate the penny stock financing in the 1990s, by modeling (per a mentor’s guidance) on the 1960s success of the local predecessor of Teledyne Waterpik, was a bad mistake as it turned out. We learn from mistakes…

I was raised and educated initially in Prague (Praha) when it was still capital of Czechoslovakia (now it’s the Czech Republic and Slovakia, after a peaceful split). Having managed to get away from the then communist regime, I did my postgraduate work in the UK (PhD). Afterward, I was a postdoc in USA (Colorado) and in London.

I embarked on my entrepreneurial career after ten stimulating years in exploratory research at the big pharmaceutical company in the UK, and I emigrated with the venture and my young family to the US (kind of per Greeley’s dictum “Go West, Young Man”).

See my and bioZhena Corporation’s mission at — and for her physicians. Do peruse this document if you are seriously interested in the project. Or in the subject matter.

For Assumptions of Our Minimum Viable Product Scenario go to . But of course my purpose and ambition is really along the lines of the Full Value Scenario. The plan:

bioZhena Corp. is pre-revenue, looking for the right investor. And I seek the right EVP/COO. Seeking for the role a person I will be able to rely on, and seeking other #CXO caliber people. #bioZhena’s #CFO should be experienced with reversed merger into a publicly traded company (recently proposed), and other ways of raising capital; and well-matched #CMO, and #CTO.  Successor #CEO from within the management team… Some serious seeks!

Contact data: Email: vaclav AT biozhena DOT com .
Tel.: 970-484-1272 (please email to schedule the call, send your info). That is, provided that the above Tweetroducing slide deck resonates with you, and that you therefore also reviewed the therein-linked Transforming Women’s Reproductive Health Management set of 11 slides, most of them narrated by yours truly. In that case, so long, till we talk…

This page was brought here from on September 26, 2019 (and touched up a bit afterwards).

%d bloggers like this: